1. Home
  2. TOP vs NVAX Comparison

TOP vs NVAX Comparison

Compare TOP & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOP Financial Group Limited

TOP

TOP Financial Group Limited

HOLD

Current Price

$16.73

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.20

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOP
NVAX
Founded
2015
1987
Country
Singapore
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
TOP
NVAX
Price
$16.73
$9.20
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$11.33
AVG Volume (30 Days)
143.3K
4.2M
Earning Date
01-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
81.25
309.76
EPS
N/A
N/A
Revenue
$4,723,765.00
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
41.89
64.69
52 Week Low
$0.61
$6.20
52 Week High
$16.35
$11.85

Technical Indicators

Market Signals
Indicator
TOP
NVAX
Relative Strength Index (RSI) 79.37 58.65
Support Level $1.01 $8.42
Resistance Level N/A $8.99
Average True Range (ATR) 1.17 0.41
MACD 0.11 0.14
Stochastic Oscillator 92.61 65.28

Price Performance

Historical Comparison
TOP
NVAX

About TOP TOP Financial Group Limited

TOP Financial Group Ltd is operates as an online brokerage firm in Hong Kong specializing in the trading of local and overseas equities, futures, and options products. It conduct the futures and stock brokerage business through three trading platforms, Esunny for futures trading and Longbridge for stock trading, all of which were licensed from third parties and can be easily accessed through its application, or APP, software, and websites. The three platforms are designed for seamless, efficient, and secure trading platform. The company operates and manages its business as a single operating and reportable segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: